We are pleased to announce that the Scleroderma Education Project has just started a new YouTube educational channel. Our first video is an overview of the research literature on therapeutic plasma [...]
For those of you interested in autologous stem cell transplants, this paper was just published open access in "Clinical Rheumatology": https://link.springer.com/article/10.1007/s10067-017-3954-5. Autologous HSCT may be an appropriate treatment option to [...]
This article was supplied to me courtesy of Dr. Allan Metzger*, Medical Director of RDL Reference Lab in Los Angeles. It is an anecdotal guest column in the publication "The [...]
Thomas A. Medsger, Jr., MD University of Pittsburg School of Medicine I just found a recent presentation by Dr. Thomas Medsger on the clinical significance of autoantibodies in systemic scleroderma. [...]
It is very common to read in articles about systemic scleroderma that there are about 300,000 people in the US with this disease. This number is completely wrong, according to numerous research studies. [...]
Background – 25 Years Ago The names used for referring to the scleroderma family of disease are very confusing for a number of reasons. Historically, there were two known forms of [...]
This article was prompted by a post in one of the scleroderma focused Facebook support groups that I am active in. The poster indicated that she had read an article [...]
This morning, NPR did a report on dangers associated with long-term use of proton pump inhibitors such as Prilosec (omeprazole) and also the fact that it is nearly impossible to [...]
In late 2013, the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) approved a new set of diagnostic criteria for systemic Scleroderma, replacing the older 1980 [...]
Estamos contentos de anunciar que acabamos de traducir la Guía para Nuevos y Futuros Pacientes” en Español. Este debe ayudar en hacer más disponible esta información importante a la comunidad [...]
